Akut mieloid leukémia (AML): vizsgálatok itt: Portugália
11 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 14.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleStudies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- Where
- Braga, Lisbon, Porto
- Életkor
- 18 év and over
- People
- 1300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT07007312 · EU 2025-521314-25-00 - 3. fázisTaking peopleA Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Where
- Lisbon, Porto
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06852222 · EU 2024-520154-38-00 - 3. fázisTaking peopleIMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
- Where
- Lisbon
- Életkor
- 18 év and over
- People
- 339 worldwide
- Run by
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
See details and how to joinNCT06713837 · EU 2024-514517-35-00 - 3. fázisNot yet taking people in PortugáliaStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Coimbra, Lisbon, Porto
- Életkor
- 12 év and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - 3. fázisTaking peopleCHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML)
- Where
- Coimbra, Lisbon, Porto
- Életkor
- Up to 64 év
- People
- 675 worldwide
- Run by
- Prinses Maxima Centrum voor Kinderoncologie B.V.
See details and how to join2023-504999-25-00 - 2. fázisNot yet taking people in PortugáliaOral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients
- Where
- Aveiro, Funchal, Lisbon, Porto
- Életkor
- 18 év and over
- People
- 50 worldwide
- Run by
- PETHEMA Foundation
See details and how to joinNCT07507760 - 2. fázisNot yet taking people in PortugáliaA study to evaluate the safety and efficacy of oral decitabine plus ivosidenib in newly diagnosed adult patients with acute myeloid leukemia older than 60 years and/or inelegible for standard induction chemotherapy
- Where
- Aveiro, Funchal, Lisbon, Matosinhos
- Életkor
- 18 év and over
- People
- 62 worldwide
- Run by
- Fundacion PETHEMA
See details and how to join2025-523238-17-00 - 3. fázisBefejeződöttAn Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
- Where
- Coimbra, Lisbon, Porto
- Életkor
- 18 év and over
- People
- 245 worldwide
- Run by
- Servier Affaires Médicales
See details and how to joinNCT05907057 · EU 2022-501709-11-00 - 2. fázisTaking peopleCHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
- Where
- Coimbra, Lisbon, Porto
- Életkor
- 1 hónap to 18 év
- People
- 60 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT06262438 · EU 2023-505000-27-01 - No phaseNot yet taking people in PortugáliaEffectiveness of Early Intervention in Palliative Care for Acute Myeloid Leukemia Patients Comparing to Standard of Care
- Where
- Porto
- Életkor
- Up to 70 év
- People
- 50
- Run by
- Universidade do Porto
See details and how to joinNCT06848270 - 2. fázisNot yet taking people in PortugáliaTreatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
- Where
- Coimbra, Lisbon, Porto
- Életkor
- Up to 18 év
- People
- 89 worldwide
- Run by
- Associazione Italiana Ematologia Oncologia Pediatrica
See details and how to joinNCT04793919 · EU 2024-518669-83-00